US Patent 7892546 Anti-CXCR4 antibodies
Patent 7892546 was granted and assigned to Eli Lilly and Company on February, 2011 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7892546 Anti-CXCR4 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
